shr-a2102
mAbexperimental
Clinical trial activity
19 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
16
Phase 3
2
Phase 4
0
Earliest trial started Mar 3, 2023 (NCT05735275)
Timeline
Indications
Mechanism of action
- Nectin-4INHIBITOR
NECTIN4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07229729 | Phase 2 | Nov 30, 2025 | Hengrui Therapeutics, Inc. |
| NCT07175220 | Phase 2 | Oct 9, 2025 | Hengrui Therapeutics, Inc. |
| NCT07059221 | Phase 1/Phase 2 (Phase 2) | Jul 11, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT07041437 | Phase 2 | Jun 30, 2025 | Fudan University |
| NCT06955390 | Phase 1/Phase 2 (Phase 2) | May 1, 2025 | Henan Medical University |
| NCT06879145 | Phase 2/Phase 3 (Phase 3) | Apr 25, 2025 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT06895928 | Phase 2 | Mar 28, 2025 | Hengrui Therapeutics, Inc. |
| NCT06819319 | Phase 2 | Mar 1, 2025 | Henan Medical University |
| NCT06738251 | Phase 3 | Dec 31, 2024 | Hengrui Therapeutics, Inc. |
| NCT06654440 | Phase 2 | Nov 30, 2024 | Hengrui Therapeutics, Inc. |
| NCT06639347 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2024 | Hengrui Therapeutics, Inc. |
| NCT06649331 | Phase 2 | Oct 21, 2024 | Fudan University |
| NCT06547736 | Phase 2 | Sep 30, 2024 | Fudan University, Hengrui Therapeutics, Inc. |
| NCT06589778 | Phase 1/Phase 2 (Phase 2) | Sep 27, 2024 | Hengrui Therapeutics, Inc. |
| NCT06512051 | Phase 1/Phase 2 (Phase 2) | Jul 30, 2024 | Hengrui Therapeutics, Inc. |
| NCT06474468 | Phase 1/Phase 2 (Phase 2) | Jun 20, 2024 | Hengrui Therapeutics, Inc. |
| NCT06417554 | Phase 1/Phase 2 (Phase 2) | May 31, 2024 | Hengrui Therapeutics, Inc. |
| NCT05701709 | Phase 1 | Apr 6, 2023 | Hengrui Therapeutics, Inc. |
| NCT05735275 | Phase 1 | Mar 3, 2023 | Hengrui Therapeutics, Inc. |
Showing 19 of 19 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 13 | 12 | 3 | 2023 |
| Fudan University | Academic/Hospital | 3 | 3 | 1 | 2024 |
| Henan Medical University | Academic/Hospital | 2 | 2 | 1 | 2025 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 2 | 2 | 2 | 2025 |
4 organizations
Page 1 / 1